Dr. rer. nat. Tina Jost

Lehrstuhl für Strahlentherapie Department of Radiation Oncology

Corrigendum: Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC (Frontiers in Oncology, (2024), 14, (1460150), 10.3389/fonc.2024.1460150) (2025) Meidenbauer J, Wachter M, Schulz S, Mostafa N, Zülch L, Frey B, Fietkau R, et al. Journal article, Erratum Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells (2025) Szwed M, Jost T, Majka E, Gharibkandi NA, Majkowska-Pilip A, Frey B, Bilewicz A, et al. Journal article Gender parity in radiation oncology in Germany: a 2024 analysis of professional roles and academic training (2025) Besserer A, Jost T, Wittig A, Schmidt L, Deloch L, Caglayan L, Flechl B, et al. Journal article Immunological effects of radiotherapy: Systemic effects of local treatment Immunologische Effekte der Strahlentherapie: Systemische Wirkungen lokaler Behandlungen (2025) Gaipl U, Donaubauer AJ, Jost T, Putz F, Frey B Journal article The Effect of Ionizing Irradiation on the Autotaxin-Lysophasphatidic Acid Axis and Interleukin-6/8 Secretion in Different Breast Cancer Cell Lines (2024) Promny T, Scherrer I, Kadam S, Schmid R, Jost T, Distel L, Arkudas A, et al. Journal article Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC (2024) Meidenbauer J, Wachter M, Schulz S, Mostafa N, Zülch L, Frey B, Fietkau R, et al. Journal article A concept of dual-responsive prodrugs based on oligomerization-controlled reactivity of ester groups: an improvement of cancer cells versus neutrophils selectivity of camptothecin (2024) Klemt I, Reshetnikov V, Dutta S, Bila G, Bilyy R, Cuartero IC, Hidalgo A, et al. Journal article, Original article Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells (2023) Grottker F, Gehre S, Reichardt C, Sengedorj A, Jost T, Rieckmann T, Hecht M, et al. Journal article DNA as the main target in radiotherapy—a historical overview from first isolation to anti-tumour immune response (2023) Frey B, Borgmann K, Jost T, Greve B, Oertel M, Micke O, Eckert F Journal article, Review article Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2022) Jost T, Faulhaber EM, Symank JA, Scheper J, Bürkel F, Fietkau R, Hecht M, Distel L Conference contribution, Abstract of a poster